Thank you to our speakers, sponsors, and delegates who joined us in London for the summit! If you are interested in the 2025 event, please get in touch at info@hansonwade.com

Develop, Validate & Implement Innovative Technologies & Analytical Methods to Satisfy Complex European Regulatory Requirements for Potency, Safety & Efficacy  

Welcome to the 3rd Cell Therapy Analytical Development Summit Europe

Defining & Refining Analytics from IND/IMPD to Clinic

In September 2024, the 3rd Cell Therapy Analytical Development Summit Europe returned to London to tackle regulatory bottlenecks head-on, make sure your company is represented. This summit was an unmissable summit to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA.

Join us in 2025, for the chance to connect with analytical development and quality control experts from industry leaders like Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson & Johnson, GSK, to tackle challenges from product characterisation to method validation and release preparation.  

Register your interest today, to collaborate, connect and share insights to drive the future development of potent, safe and effective autologous and allogeneic cell therapies forward.

15+

Expert Speakers

7+

Hours of Networking

2

NEW Workshops

The 2024 World-Class Speaker Faculty Included:

"The 2024 summit presents a unique opportunity to connect with industry leaders and forge collaborations while offering invaluable insights into fast-developing techniques and state-of-the-art technologies that are shaping the future of our industries."
– Matthijs Koorevaar, Director, Quality Control, Johnson & Johnson (2024 Speaker)

2024 Attending Companies Included:

Companies + Dels in the Room - CTx AD EU

"In a time where cell therapy is expanding, this summit serves as a forum for specialists to shape and elevate analytical benchmarks, ensuring that potency, characterisation, and multi-region access cease to be obstacles in the cell therapy drug development process."
-
Diego Vázquez, Senior Manager Quality Control Analytical,
Bristol Myers Squibb (2024 Speaker)

Our 2024 Partners:

"Cell therapy analytics are rapidly developing, it is important to take time to see what is happening in the field and what solutions have been successfully deployed. The European analytical summit serves that function well."
Benjamin Espen, Principal Quality Engineer, Avobis Bio, LLC (2024 Speaker)

Your Event Event in the Series:

Join us in Boston for the 6th Annual Cell Therapy Analytical Development Summit to engage with experts and overcome challenges in product characterisationmethod validationrelease, and scale-up.